Leading GMP cell therapy CDMO I Peace, Inc. ( specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that it has successfully generated human induced ...

While current clinical trials for cardiac regeneration using induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) ...

Southwest Research Institute (SwRI) has demonstrated a new application for its cell-expansion bioreactor to advance tissue engineering and cell-based therapies for treatment of injuries and diseases.

The ability to reprogram adult somatic cells into human induced pluripotent stem cells (hiPSCs), and to differentiate them ...

Parkinson's disease is a progressive neurodegenerative disorder that affects more than one million people in the United States, with approximately 90,000 new cases diagnosed each year. Although ...

The big picture: Nearly two decades ago, Shinya Yamanaka and Kazutoshi Takahashi discovered they could turn mature somatic cells back into stem cells. The scientists predicted these new cells could be ...

James Marchant is a postdoctoral researcher in Alexandre Colas’s group at Sanford Burnham Prebys. In this Postdoc Portrait, he shares his work on developing a gene therapy for heart failure, why his ...

DUBLIN--(BUSINESS WIRE)--The "Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, & Forecasts, 2025" report has been added to ResearchAndMarkets.com's offering. Since the ...